Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Journal of the American Academy of Dermatology
|
November 10, 2024
Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: Primary results from a randomized phase 2 study
Jean Carruthers, Steven Liew, Jason K Rivers, et al.
Journal of Drugs in Dermatology : JDD
|
January 6, 2025
Expert Recommendations on the Use of a New Hyaluronic Acid Injectable for the Aesthetic Treatment of the Chin and Lower Face
Andreas Nikolis, Katie Beleznay, Vince Bertucci, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 29, 2015
Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure
Jason K Rivers, Vince Bertucci, William McGillivray, et al.
Aesthetic Surgery Journal. Open Forum
|
February 20, 2025
Canada HARMONY Study: Improvements in Patient Satisfaction With Facial Appearance and Psychological Impact of Combined Aesthetic Treatment
Jason K Rivers, Vince Bertucci, Channy Muhn, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 9, 2025
NivobotulinumtoxinA in the Treatment of Lateral Canthal Lines Alone and With Concurrent Treatment of Glabellar Lines
Jean Carruthers, Janet C DuBois, Daniel P Friedmann, et al.
SAGE Open Medicine
|
December 17, 2021
Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic
Jason K Rivers, John P Arlette, Joel DeKoven, et al.
Journal of Drugs in Dermatology : JDD
|
April 2, 2024
Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion
Andreas Nikolis, Shannon Humphrey, Jason K Rivers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2024
Efficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study
Glynis Ablon, David Bank, Theda C Kontis, et al.
Plastic and Reconstructive Surgery
|
April 19, 2024
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Platysma Prominence: A Randomized Phase 2 Dose-Ranging Study
Rod J Rohrich, Vince Bertucci, Steven Dayan, et al.
Journal of Cutaneous Medicine and Surgery
|
May 22, 2016
Canadian Clinical Practice Guidelines for Rosacea
Yuka Asai, Jerry Tan, Akerke Baibergenova, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Journal of the American Academy of Dermatology
|
November 10, 2024
Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: Primary results from a randomized phase 2 study
Jean Carruthers, Steven Liew, Jason K Rivers, et al.
Journal of Drugs in Dermatology : JDD
|
January 6, 2025
Expert Recommendations on the Use of a New Hyaluronic Acid Injectable for the Aesthetic Treatment of the Chin and Lower Face
Andreas Nikolis, Katie Beleznay, Vince Bertucci, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 29, 2015
Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure
Jason K Rivers, Vince Bertucci, William McGillivray, et al.
Aesthetic Surgery Journal. Open Forum
|
February 20, 2025
Canada HARMONY Study: Improvements in Patient Satisfaction With Facial Appearance and Psychological Impact of Combined Aesthetic Treatment
Jason K Rivers, Vince Bertucci, Channy Muhn, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 9, 2025
NivobotulinumtoxinA in the Treatment of Lateral Canthal Lines Alone and With Concurrent Treatment of Glabellar Lines
Jean Carruthers, Janet C DuBois, Daniel P Friedmann, et al.
SAGE Open Medicine
|
December 17, 2021
Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic
Jason K Rivers, John P Arlette, Joel DeKoven, et al.
Journal of Drugs in Dermatology : JDD
|
April 2, 2024
Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion
Andreas Nikolis, Shannon Humphrey, Jason K Rivers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2024
Efficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study
Glynis Ablon, David Bank, Theda C Kontis, et al.
Plastic and Reconstructive Surgery
|
April 19, 2024
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Platysma Prominence: A Randomized Phase 2 Dose-Ranging Study
Rod J Rohrich, Vince Bertucci, Steven Dayan, et al.
Journal of Cutaneous Medicine and Surgery
|
May 22, 2016
Canadian Clinical Practice Guidelines for Rosacea
Yuka Asai, Jerry Tan, Akerke Baibergenova, et al.
Page
of 7